This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Neoplasms or Neoplasm Metastasis
and you are
over 20
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The main purpose of this study is to evaluate the safety and side effects of LY2157299 in Japanese participants with advanced cancer or cancer that has spread to other parts of the body.

Provided treatments

  • Drug: LY2157299

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01722825. The sponsor of the trial is Eli Lilly and Company and it is looking for 12 volunteers for the current phase.
Official trial title:
Phase 1 Dose-Escalation Study of LY2157299 Monotherapy in Patients With Solid Tumors